Skip to main content

Table 6 Cox-proportional HR model for incident all-cause mortality in FDAF patients stratified by electrical vs. pharmacological cardioversion

From: Effect of non-invasive rhythm control on outcomes in patients with first diagnosed atrial fibrillation presenting to an emergency department

Covariate

aHR (95%CI)

p-value

Age, per year

1.05 (1.02–1.08)

0.0011

Sex, female

0.84 (0.48–1.47)

0.5436

Diabetes mellitus

1.02 (0.54–1.96)

0.9325

Prior PAD

2.12 (1.01–4.45)

0.0476

Prior CAD

1.22 (0.63–2.35)

0.5562

Prior MI

1.10 (0.48–2.53)

0.8215

Prior cancer

0.58 (0.23–1.47)

0.2466

Mildly abnormal LVEF

0.94 (0.42–2.11)

0.9380

Moderately abnormal LVEF

1.49 (0.74–2.99)

0.2613

Severely abnormal LVEF

2.23 (1.09–4.57)

0.0284

eGFR < 60 mL/min

2.46 (1.41–4.29)

0.0015

CRP > 5 mg/L

2.52 (1.40–4.53)

0.0021

Pharmacological CV

2.51 (1.38–4.58)

0.0026

  1. Abbreviations: aHR adjusted Hazard ratio, CAD Coronary artery disease, CV Cardioversion, CI Confidence interval, CRP C-reactive protein, eGFR estimated glomerular filtration rate, LVEF Left ventricular ejection fraction, MI Myocardial infarction, PAD Peripheral artery disease